✦ LIBER ✦

A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer

✍ Scribed by T. Langenbuch; K. Mross; W. Jonat; D. K. Hossfeld

Publisher: Springer
Year: 1990
Tongue: English
Weight: 450 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685433

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ten-year follow-up of a phase 2 study of

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer

✍ Gisele A. Sarosy; Mahrukh M. Hussain; Michael V. Seiden; Arlan F. Fuller; Najmos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: The objective of this study was to assess activity and toxicity in patients with newly diagnosed, advanced‐stage epithelial ovarian cancer (EOC) who were receiving dose‐intense paclitaxel, cyclophosphamide, cisplatin, and filgrastim delivered with a flexible dosing sched

Phase II evaluation of an intensified in

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

✍ Stephen H. Petersdorf; Cathryn Rankin; David R. Head; Howard R. Terebelo; Cheryl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views